Application of DCE-MRI Based on 4D FreeBreathing in Predicting the Efficacy of Immune and Targeted Therapy in Lung Cancer

This study aims to address the challenge of predicting the efficacy of targeted and immunotherapy in lung cancer patients. By utilizing two DCE-MRI images-one before treatment and one after one treatment cycle-along with the patients' clinical and pathological information, we aim to achieve accurate prediction of the therapeutic efficacy of targeted and immunotherapy in lung cancer patients.

Trial Details

NCT ID
NCT06742021
Phase
NA
Sponsor
Yunnan Cancer Hospital
Status
RECRUITING
Cancer Type
Lung Cancer
Interventions
  • Application Value of MRI Imaging in Treatment Decision-Making for Lung Cancer
Locations (sample)
  • Kunming, Yunnan, China|25.03889,102.71833

Key Eligibility Criteria

  • Tumor size greater than 2 cm
  • Age between 18 and 75 years

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lung Cancer Trials on Trialify →